Vaxart, Inc. Restructuring Reserve
Vaxart, Inc. (VXRT) had Restructuring Reserve of $0 as of 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2022-02-24
- 2021-12-31: Restructuring Reserve $0.00.
- 2020-12-31: Restructuring Reserve $0.00.
- 2020-09-30: Restructuring Reserve $14.00K.
- 2020-06-30: Restructuring Reserve $3.23M.
| Period end | Restructuring Reserve | Restructuring Reserve as first filed |
|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-24 | |
| 2020-12-31 | $0.00 10-K · filed 2022-02-24 | |
| 2020-09-30 | $14.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $3.23M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $3.23M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $3.65M 10-K · filed 2022-02-24 | |
| 2018-12-31 | $0.00 10-K · filed 2022-02-24 | $233.00K 10-K · filed 2019-02-06 |
| 2015-03-31 | $700.00K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $800.00K 10-Q · filed 2015-02-06 | |
| 2014-09-30 | $1.40M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $2.00M 10-K · filed 2015-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |